"Oct. 31, 2012 -- Two new trials offer proof that a leukemia drug long used to treat multiple sclerosis works better than a common treatment.
When compared with the widely used drug interferon beta, the leukemia drug alemtuzumab reduce"...
Safety of doses higher than 0.25 mg every other day has not been adequately evaluated. The maximum amount of interferon beta-1b that can be safely administered has not been determined.
EXTAVIA (interferon beta-1b kit) is contraindicated in patients with a history of hypersensitivity to natural or recombinant interferon beta, Albumin (Human), USP, or any other component of the formulation.
Last reviewed on RxList: 9/16/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Extavia Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.